The Genzyme (GENZ) play is about more than Sanofi-Aventis (SNY) looking for growth. It reflects Big Pharma's push into treating rare illnesses, with the assumption that niche diseases can be a good way to fatten margins, and product pipelines, that are under pressure elsewhere.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Feb 19, 2015)
at Benzinga.com (Feb 5, 2015)
at Benzinga.com (Jan 15, 2015)
at CNBC.com (Jan 9, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs